Market Place
Sourcing Support
Enforcement Report - Week of May 29, 2024
29 May 2024 //
FDA
Thea Pharma Inc. Launches IYUZEH 0.005% in the U.S.
26 Sep 2023 //
PR NEWSWIRE
Cayman Chemical Receives CEP for Latanoprost API from EDQM
12 Sep 2023 //
PRESS RELEASE
IYUZEH Demonstrated Similar IOP Lowering Efficacy when Compared to Xalatan
03 Mar 2023 //
PR NEWSWIRE
Thea gets FDA nod for preservative-free rival to Viatris drug
20 Dec 2022 //
FIERCEPHARMA
Thea Pharma Announces FDA Approval of IYUZEH for Reduction of IOP
15 Dec 2022 //
BUSINESSWIRE
Alcon Completes Acquisition of Aerie Pharmaceuticals
22 Nov 2022 //
BUSINESSWIRE
TearClear Announces Positive Topline Results from CLEAR Phase 3 Study
29 Sep 2022 //
GLOBENEWSWIRE
Aerie Announces 1st Participant Dosed in COMET-3 Study of AR-15512
01 Aug 2022 //
BUSINESSWIRE
TearClear successfully initiates of TC-002 Latanoprost Ophthalmic Solution
07 Feb 2022 //
GLOBENEWSWIRE
Aerie Concludes Exclusive License Agreement With Santen for Rhopressa, Rocklatan
07 Dec 2021 //
PRESS RELEASE
NCX470 Significant Intraocular Pressure Lowering in Dolomites Ph2 Glaucoma Trial
01 Jul 2021 //
GLOBENEWSWIRE
Nicox’s Licensee Bausch + Lomb Receives Approval for VYZULTA®
25 Jun 2021 //
GLOBENEWSWIRE
Meeting highlights from the Committee for Medicinal Products for Human Use
13 Nov 2020 //
EMA
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa®
27 Oct 2020 //
BUSINESSWIRE
Aerie Pharma Announces Successful Interim Data From Its Mercury 3 Clinical Trial
24 Sep 2020 //
BUSINESSWIRE
Nicox Completes Enrollment of the Adaptive Design Cohort of NCX 470
02 Sep 2020 //
GLOBENEWSWIRE
Aerie Pharmaceuticals Submits Marketing Authorisation Application for Roclanda
03 Dec 2019 //
BUSINESS WIRE
QBiotics Announces 1st Patient Dosed in its Phase I/II Trial of Tigilanol
03 Dec 2019 //
PR NEWSWIRE
Enforcement Report - Week of August 7, 2019
07 Aug 2019 //
FDA
Program to boost access to Xelpros in USA
19 Jul 2019 //
THE PHARMALETTER
Indoco Remedies Fails EDQM Inspection
22 Jan 2019 //
EDQM
Sun Pharma launches Xelpros in US
11 Jan 2019 //
INDIA INFOLINE
Nicox teams up with Chinese firm to develop and sell glaucoma drug
17 Dec 2018 //
REUTERS
Aerie Announces Early Notification of FDA Acceptance of NDA Sub for Roclatan™
27 Jul 2018 //
PRESS RELEASE
Aerie Pharma Announces FDA Acceptance of NDA for Roclatan
23 Jul 2018 //
BUSINESSWIRE
Aerie Submits NDA to U.S. Food and Drug Administration for RoclatanTM
15 May 2018 //
PRESS RELEASE
Imprimis Pharmaceuticals Receives FDA Warning Letter
17 Jan 2018 //
FDA
FDA’s year-end approvals take annual tally to 46
02 Jan 2018 //
PMLIVE
Enforcement Report - Week of September 13, 2017
13 Sep 2017 //
FDA
Enforcement Report - Week of April 19, 2017
19 Apr 2017 //
FDA
Indoco injectables plant smacked with FDA warning letter
06 Apr 2017 //
FIERCE PHARMA
US FDA hits Indoco with warning due to leaky glaucoma drug
05 Apr 2017 //
IN PHARMATECHNOLOGIST
Valeant indicates Bausch plant responsible for CRL now ready to go
22 Mar 2017 //
FIERCE PHARMA
Aerie to build manufacturing facility in Ireland
12 Jan 2017 //
IN PHARMATECHNOLOGIST
Inotek`s eye drug fails late-stage study, shares sink
03 Jan 2017 //
REUTERS
Forbidden Xalacom Eye Drops of Pfizer
21 Oct 2016 //
ANVISA
Obama administration rejects congressional push to override drug patents
08 Mar 2016 //
STAT
Merck and Sun Pharma part company on branded generics
16 Feb 2016 //
PM LIVE
Sun Pharmaceutical’s opthalmic biz foray positive
11 Jun 2015 //
THE FINANCIAL EXPRESS
pSivida Corp. Reports ILUVIEN® for DME Approved in Poland
14 Apr 2015 //
PSIVIDA
New Wave of Drugs Poised to Shake Up Glaucoma Treatment
16 Feb 2015 //
REUTERS
